Behind the Test – Our New LinkedIn Newsletter

Published

Integrity Sampling is excited to launch Behind the Test, our brand-new monthly LinkedIn newsletter. This newsletter is designed to give you practical insights into workplace drug and alcohol testing, drawing from real-world situations we see every day across Australia.

Each issue will tackle challenges that employers and safety managers face, while offering clear, actionable advice to help you support your people—safely and fairly.

Issue #1: ADHD Medications & Workplace Drug Testing

Our first edition dives into one of the biggest emerging challenges in workplace testing: how ADHD medications can impact drug test results.

Inside, we explore:

  • Why prescriptions like Ritalin and Dexamphetamines may trigger non-negative results.
  • The employer’s balancing act between fairness and safety.
  • How Medical Review Officers (MROs) play a vital role in ensuring fair outcomes.
  • A real-world case study where delays could have been avoided with better policy clarity.
  • Four practical steps your workplace can take right now.

Why Subscribe?

Workplace drug and alcohol testing is complex and constantly evolving. With Behind the Test, you’ll:

  • Stay ahead of regulatory challenges.
  • Gain clarity on tricky testing issues.
  • Get expert tips you can implement straight away.
  • Learn from real examples across industries.

Read Issue #1 now and subscribe here.

By Michael

Michael is the founder of Integrity Sampling and is responsible for overseeing all national operations. He is based at Integrity Sampling's head office in Melbourne and is also responsible for the co-ordination of drug and alcohol testing within Victoria, assisting in the implementation of drug and alcohol (fit for work) policies and the presentation of drug and alcohol education and awareness programs. You can connect with Michael Wheeldon on LinkedIn

Leave a comment